Sie sind auf Seite 1von 3
Breastfeeding linked with long-term reduction in obesity 10 July 2012 Women who breastfed their children

Breastfeeding linked with long-term reduction in obesity

10 July 2012

Women who breastfed their children have a lower body mass index (BMI) than those who did not, even decades after giving birth, according to new research funded by Cancer Research UK and the Medical Research Council (MRC).

A study of 740,000 post-menopausal UK women, published in the International Journal of Obesity, found that both childbearing and breastfeeding had significant, but opposite, effects on long-term weight.

The more children a woman had, the higher her BMI decades later. However, the average BMI was significantly lower in women who breastfed than in those who had not, regardless of how many children they had.

For every six months women had breastfed, their BMI was 1 per cent lower, even after accounting for other factors known to affect to obesity such as smoking, exercise and social deprivation.

Professor Dame Valerie Beral, Director of the Cancer Epidemiology Unit at the University of Oxford and study co-author, said:

“Our research suggests that just six months of breastfeeding by UK women could reduce their risk of obesity in later life. A one per cent reduction in BMI may seem small, but spread across the population of the UK that could mean about 10,000 fewer premature deaths per decade from obesity-related conditions, such as diabetes, heart disease and some cancers.”

Dr Kirsty Bobrow, also from the University of Oxford and lead author of the paper, said:

“We already know breastfeeding is best for babies, and this study adds to a growing body of evidence that the benefits extend to the mother as well – even 30 years after she’s given birth. Pregnant women should be made aware of these benefits to help them make an informed choice about infant feeding.”

Sara Hiom, Director of Information at Cancer Research UK, said:

“We already know that breastfeeding can reduce a woman’s risk of developing breast cancer. And this study highlights that

breastfeeding may also be linked to weight. Weight in turn influences the likelihood of developing some cancers as well as other diseases. Too few people know about the significant cancer risks associated with being very overweight.”

Professor Dame Sally Macintyre, Director of the MRC/Chief Scientist Office Social and Public Health Sciences Unit, said:

“The obesity epidemic is one of the biggest challenges facing both high income and, increasingly, low and middle income countries. Rates of obesity are continuing to rise. Studies such as this one, which look at broad trends within a large population, can help us to develop effective strategies to prevent obesity and its related diseases.”

Previous research has shown that breastfeeding can help women lose weight accumulated during pregnancy in the months immediately after birth, but fewer studies have addressed the relationship with long-term BMI.

The researchers carried out a cross-sectional study of women who were participants in the Million Women Study, which investigates how various reproductive and lifestyle factors affect women’s health. Women were asked about their height, weight, reproductive history and other relevant factors.

The average age of the women in the study was 57.5 and the mean BMI was 26.2 kg/m 2 . Most of the women had had at least one child (88 per cent) and of these 70 per cent had breastfed, on average for 7.7 months.

More research is needed to find out whether this effect is observed in other populations – particularly in developing countries where childbearing and breastfeeding patterns are very different to those in the UK.

Notes to editors

For more information or to speak to Prof Valerie Beral, please contact:

Hannah Isom

Senior Press Officer, Medical Research Council

T: 0207 395 2345 (out of hours: 07818 428 297)


1. The paper: ‘Persistent effects of women’s parity and breastfeeding histories on their body mass index: results from the Million Women Study’, by Bobrow et al, is published in the International Journal of Obesity, (2012).


The Million Women Study, funded by Cancer Research UK and the Medical

Research Council, is a prospective study of 1.3 million women aged between 50 and 64 years when they were invited for screening by the NHS Breast Screening Programme in England and Scotland between 1996 and 2001.

3. For almost 100 years the Medical Research Council has improved the health

of people in the UK and around the world by supporting the highest quality science. The MRC invests in world-class scientists. It has produced 29 Nobel Prize winners and sustains a flourishing environment for internationally recognised research. The MRC focuses on making an impact and provides the financial muscle and scientific expertise behind medical breakthroughs, including one of the first antibiotics penicillin, the structure of DNA and the lethal link between smoking and cancer. Today MRC funded scientists tackle research into the major health challenges of the 21st century.

4. Cancer Research UK is the world’s leading cancer charity dedicated to saving

lives through research. The charity’s groundbreaking work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. This work is

funded entirely by the public. Cancer Research UK has been at the heart of the progress that has already seen survival rates in the UK double in the last forty years. Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses. Together with its partners and supporters, Cancer Research UK's vision is to beat cancer. For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1861 or visit Follow us on Twitter and Facebook

5. Oxford University’s Medical Sciences Division is one of the largest biomedical

research centres in Europe, with over 2,500 people involved in research and more than 2,800 students. The University is rated the best in the world for medicine, and it is home to the UK’s top-ranked medical school. From the genetic and molecular basis of disease to the latest advances in neuroscience, Oxford is at the forefront of medical research. It has one of the largest clinical trial portfolios in the UK and great expertise in taking discoveries from the lab into the clinic. Partnerships with the local NHS Trusts enable patients to benefit from close links between medical research and healthcare delivery. A great strength of Oxford medicine is its long-standing network of clinical research units in Asia and Africa, enabling world-leading research on the most pressing global health challenges such as malaria, TB, HIV/AIDS and flu. Oxford is also renowned for its large-scale studies which examine the role of factors such as smoking, alcohol and diet on cancer, heart disease and other conditions.